Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.29% to 9250.43, DAX +0.23% to 23666.81, CAC40 (0.57%) to 7827.45, STOXX 600 (0.19%) to 553.88

Sep 24 ,2025

  • Synopsis:

    • European equity markets closed mixed with UK and Germany near session highs and France lower. Basic resources, energy and utilities were the best performing sectors; construction, personal goods and chemicals lagged. Follows positive close on Tuesday.

    • Risk appetite softer following softer-than-expected economic data and comments from Fed's Powell. Focus also on geopolitics, as Trump met with Zelenskiy at US General Assembly and later declared Ukraine could retake all occupied territory, citing Russia's economic struggles. Kyiv welcomed remarks as "big shift," though no new US policy measures, such as additional sanctions, were announced.

    • German Chancellor Merz rejected criticism of social reforms. Press reports suggest EU-US trade talks to restart.

    • On the macro front, German IFO business climate index missed expectations as companies less satisfied with current conditions and increasingly pessimistic about the outlook. Comes as German economy contracted by (0.3%) in Q2 due to slowing US demand following tariff-related stockpiling. Elsewhere, Spain Aug PPI declines (1.5%) y/y vs consensus for a +0.1% increase and prior revised +0.4% from +0.3%. Also, Switzerland Sep ZEW Expectations came in below expectation (46.4) vs consensus (40.0) but improves from prior (53.8). Switzerland's KOF institute sees much lower growth in 2026 citing US Tariffs. In the UK, Ofgem reportedly to require all major suppliers to offer lower standing charge tariffs by the end of Jan-2026. UK pay settlements held at 3% in the three months to Aug as inflation remained elevated.

    • In corporate reporting, JD Sports Fashion (JD.LN) posted H1 whilst - from several CMDs taking place today - Iberdola (IBE.SM) now sees EBITDA to reach €18B by 2028, Metso Corp (METSO.FH) updated its strategy for 2026-30 and released new financial targets and CTP NV (CTPNV.NA) also confirmed its FY25 EPRA EPS target at its CMD.

    • On a busy syndicate desk, Asker Healthcare (ASKER.SS) holder Sjätte AP-fonden sold ~38M shares at SEK81/each, Exail Technologies (EXA.FP) places a €300M convertible bond, Envipco Holding (ENVI.NA) priced a NOK 630M private placement and Yellow Cake (YCA.LN) raised ~$125M (equivalent to £92.5M).

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Basic Resources +1.83%, Oil & Gas +1.52%, Utilities +0.61%, Food & Beverage +0.09%, Ind Goods & Svcs +0.08%, Banks +0.05%, Retail (0.05%), Real Estate (0.06%), Telecom (0.15%)

      • Underperformers:

        • Construct & Mtls (1.21%), Persnl & HHold Goods (1.19%), Chemicals (1.14%), Financial Svcs (1.05%), Health Care (0.65%), Autos & Parts (0.63%), Media (0.42%), Technology (0.37%), Insurance (0.35%), Travel & Leisure (0.32%)

    • Macro:

      • Geopolitics:

        • Trump backs NATO action, supports Ukraine's territorial recovery (AlJazeera, SCMP)

        • Zelenskiy thinks Trump could help change Xi's position on Russia's war in Ukraine (Reuters )

      • Central Banks:

        • ECB sees balanced inflation risks, rates well-positioned (Bloomberg)

        • SNB likely to avoid negative rates (Bloomberg)

        • Danish Central Bank cuts outlook amid Novo troubles, US Tariffs (Bloomberg )

      • Germany:

        • German business outlook declines for first time since April (Bloomberg )

        • German institutes raise 2025 growth forecast amid trade challenges (Reuters)

        • Germany pushes for EU defense leadership, joint arms projects (FT)

      • Markets:

        • Europe's asset managers consolidate to counter US dominance (Bloomberg)

      • UK:

    • Company news:

      • Notable Gainers

        • +22.0% GDWN.LN (Goodwin £136.00, +24.50) -- trading update; partnership

        • +21.6% ASAI.LN (ASA International Group £2.08, +0.37) -- H1 earnings

        • +18.6% CLCO.NO (Cool Co. NOK92.50, +14.50) -- EPS Ventures Ltd agrees in principal to acquire the remainder of CoolCo for $9.65/share in cash

        • +8.3% SAGA.LN (Saga Plc £2.35, +0.18) -- H1 earnings

        • +5.2% VAR.NO (Vår Energi NOK35.21, +1.75) -- initiated buy at Citi

        • +5.0% FCT.IM (Fincantieri €21.46, +1.02) -- Italy Ministry of Defense presents ~€1.6B investment program for two new class of auxiliary vessels -- Borsa Italiana, citing "IlSole24Ore"

        • +4.9% OSE.FP (OSE Immunotherapeutics €6.12, +0.29) -- acknowledges decision of Nantes Commercial Court

        • +4.5% ATO.FP (ATOS SE €51.97, +2.26) -- contract

        • +3.6% SAV.LN (Savannah Resources £0.04, -0.00) -- H1 earnings

        • +3.3% CTPNV.NA (CTP NV €18.02, +0.58) -- CMD update

        • +3.2% BC8.GR (Bechtle €40.04, +1.26) -- BNP Paribas Exane upgrade

        • +2.7% PAX.SS (Paxman SEK69.00, +1.80) -- holder Glenn Paxman sold upsized 1.85M shares at SEK67.20/share

        • +2.3% F3C.GR (SFC Energy €17.54, +0.40) -- orders

        • +2.2% MEDCL.FP (MedinCell €22.52, +0.48) -- Risperidone LAI approved in Canada as LONGAVO

        • +1.8% AAD.GR (Amadeus FiRe €51.70, +0.90) -- acquisition

        • +1.8% ARCH.NO (Archer NOK24.95, +0.45) -- to acquire Premium Oilfield Services, LLC for total consideration of $20M; will be financed through a contemplated private placement

      • Notable Decliners

        • -19.4% OTB.LN (On The Beach Group £2.08, -0.50) -- trading update; further share buyback programme of up to £25M; to commence orderly wind down of B2B segment trading as Classic Collection

        • -14.0% PINE.LN (Pinewood Technologies Group £4.55, -0.74) -- H1 earnings

        • -13.8% ALCRB.FP (Carbios €8.47, -1.36) -- H1 earnings

        • -6.7% LXS.GR (Lanxess €22.48, -1.62) -- Deutsche Bank downgrade

        • -6.5% ASKER.SS (Asker Healthcare Group SEK83.08, -5.81) -- holder Sjätte AP-fonden sold ~38M shares at SEK81/share

        • -6.0% IMP.A.SS (Implantica SEK69.00, -4.40) -- FDA provides positive feedback on Implantica's final RefluxStop PMA submission Module 3

        • -5.8% NCAB.SS (NCAB Group SEK52.00, -3.20) -- SEB downgrade

        • -5.5% BCG.LN (Baltic Classifieds Group £2.99, -0.18) -- AGM update; lowers FY guidance

        • -4.5% SDI.LN (SDI Group £0.95, -0.05) -- trading update

        • -4.3% NOEJ.GR (Norma Group €15.18, -0.68) -- H1 earnings

        • -4.1% AVG.LN (Avingtrans £4.70, -0.20) -- FY earnings

        • -3.4% SATS.NO (SATS ASA NOK37.80, -1.35) -- ABG Sundal Collier downgrade

        • -3.2% STLAM.IM (Stellantis €8.21, -0.27) -- to reportedly pause production at some European plants due to weak demand

        • -2.4% EXA.FP (Exail Technologies €92.30, -2.30) -- completes offering of undated bonds convertible into new shares and/or exchangeable for existing shares (ODIRNANE) for a nominal amount of €300M; TPICAP Midcap downgrade

        • -2.1% EVK.GR (Evonik Industries €15.16, -0.32) -- Deutsche Bank downgrade

        • -1.8% SPM.IM (Saipem €2.40, -0.04) -- Oil firms seek Cade's intervention in Saipem-Subsea 7 merger - Reuters

        • -1.7% AXS.LN (Accsys Technologies £0.69, -0.01) -- trading update

        • -1.5% ENVI.NA (Envipco Holding €6.66, -0.10) -- pricing of NOK 630M private placement

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: OCI (OCI.NA), Fluxys Belgium (FLUX.BB), Hyloris Pharmaceuticals (HYL.BB), Celyad Oncology (CYAD.BB)

        • DACHs: KWS SAAT SE & Co. KGaA (KWS.GR), Verbio (VBK.GR)

        • France: Hexaom (ALHEX.FP), Cegedim (ALCGM.FP), OSE Immunotherapeutics (OSE.FP), Theranexus (ALTHX.FP)

        • Nordics: H&M Hennes & Mauritz (HM.B.SS)

        • Southern Europe: Athens Water Supply & Sewage Co. (EYDAP.GA), Thessaloniki Port Authority (OLTH.GA)

        • UK/Ireland: DFS Furniture (DFS.LN), Seeing Machines (SEE.LN), Hansard Global (HSD.LN), STV Group (STVG.LN), Polarean Imaging (POLX.LN), Glenveagh Properties (GVR.ID)

      • CMD/events: Infotel (INF.FP)

  • Data:

    • Economics:

      • Germany Sep IFO Business Climate 87.7 vs consensus 89.3 and prior revised 88.9 from 89.0 - link

        • Current Conditions 85.7 vs consensus 86.5 and prior 86.4

        • Expectations 89.7 vs consensus 92.0 vs prior 91.6

      • Switzerland Sep ZEW Expectations (46.4) vs consensus (40.0) and prior (53.8)

      • Aug PPI

        • Finland +0.1% vs consensus (1.3%) and prior (1.5%) (1:00ET)

        • Spain (1.5%) y/y vs consensus +0.1% and prior revised +0.4% from +0.3%

    • Markets:

      • WTI Crude (Nov 25): +$1.19 or +1.88% to $64.60

      • €-$ (0.0075) or (0.63%) to 1.1741

      • £-$ (0.0071) or (0.52%) to 1.3453

      • €-£ (0.0005) to 0.8731

      • S&P 500 (0.11%)

      • Performance year-to-date

        • FTSE 100: +13.18%

        • DAX: +18.87%

        • CAC: +6.05%

        • MIB: +24.09%

        • Stoxx 600: +9.11%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE